Unlock stock picks and a broker-level newsfeed that powers Wall Street.
ASX - Delayed Quote AUD

Emerald Resources NL (EMR.AX)

Compare
3.8500
+0.0900
+(2.39%)
At close: 4:10:39 PM GMT+11
Loading Chart for EMR.AX
  • Previous Close 3.7600
  • Open 3.6800
  • Bid 3.8500 x --
  • Ask 3.9100 x --
  • Day's Range 3.6400 - 3.9100
  • 52 Week Range 3.1500 - 4.5400
  • Volume 1,953,833
  • Avg. Volume 1,722,319
  • Market Cap (intraday) 2.531B
  • Beta (5Y Monthly) 0.88
  • PE Ratio (TTM) 25.67
  • EPS (TTM) 0.1500
  • Earnings Date Feb 26, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 4.68

Emerald Resources NL engages in the exploration and development of mineral reserves in Cambodia and Australia. The company's exploration tenements include a combination of 100% owned granted licenses, applications, and earn-in and joint venture agreements covering a combined area of 1,428 square kilometers. Its principal property is the Okvau Gold project located in the city of Phnom Penh, province of Mondulkiri. Emerald Resources NL was formerly known as Emerald Oil & Gas NL and changed its name to Emerald Resources NL in December 2014. The company was incorporated in 1969 and is headquartered in West Perth, Australia.

www.emeraldresources.com.au

322

Full Time Employees

June 30

Fiscal Year Ends

Gold

Industry

Recent News: EMR.AX

View More

Performance Overview: EMR.AX

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

EMR.AX
18.46%
S&P/ASX 200 [XJO] (^AXJO)
3.67%

1-Year Return

EMR.AX
18.10%
S&P/ASX 200 [XJO] (^AXJO)
0.54%

3-Year Return

EMR.AX
229.06%
S&P/ASX 200 [XJO] (^AXJO)
4.88%

5-Year Return

EMR.AX
940.54%
S&P/ASX 200 [XJO] (^AXJO)
55.10%

Compare To: EMR.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EMR.AX

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    2.53B

  • Enterprise Value

    2.35B

  • Trailing P/E

    25.36

  • Forward P/E

    14.81

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.74

  • Price/Book (mrq)

    3.98

  • Enterprise Value/Revenue

    5.49

  • Enterprise Value/EBITDA

    10.98

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    23.17%

  • Return on Assets (ttm)

    16.66%

  • Return on Equity (ttm)

    18.69%

  • Revenue (ttm)

    434.35M

  • Net Income Avi to Common (ttm)

    100.62M

  • Diluted EPS (ttm)

    0.1500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    217.48M

  • Total Debt/Equity (mrq)

    6.84%

  • Levered Free Cash Flow (ttm)

    198.13M

Research Analysis: EMR.AX

View More

Company Insights: EMR.AX

Research Reports: EMR.AX

View More

People Also Watch